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Abstract
© 2016, Springer Science+Business Media New York.One the current challenges of modern
hepatology is to find new approaches to stimulate liver regeneration and to find new methods
for liver disease treatment. Cell therapies, which are based on using regional stem cells for
disease  treatment,  are  under  active  development.  However,  studies,  devoted  to  their
transplantation, are currently scarce. In recent years, hepatic stellate cells are considered to be
hepatic stem cells. It is known that activated hepatic stellate cells can transdifferentiate into
myofibroblasts and lead to liver fibrosis. The aim of our work was to study the influence of
native and activated hepatic stellate cells in vivo by lead nitrate injection after transplantation
into partial hepatectomized rats, which is considered to be a classical model to study liver
regeneration. Injection of 2-acetylaminofluorene (AAF), which selectively eliminates hepatocyte
proliferation, was used to understand the hepatic stellate cells role in liver regeneration process
better. Our results suggest that transplanted native and activated hepatic stellate cells can
differentiate  into  hepatocyte-like  cells  and  positively  influence  liver  regeneration  without
inducing liver fibrosis.
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